Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel bioenzymatic route for high-purity pseudouridine. Reduces cost and environmental impact for pharmaceutical intermediates manufacturing.
Novel Boc-protection strategy for high-purity Raltitrexed intermediate. Reduces side reactions, improves yield, ensures supply chain stability for pharma manufacturing.
Patent CN114292240A details a robust two-step synthesis for Trelagliptin degradation impurities, ensuring high-purity API quality control and reliable supply chain continuity.
Patent CN102010361B reveals a novel etherification route for amlodipine intermediates, offering significant yield improvements and enhanced process scalability for global API manufacturers.
Patent CN104003946A details a high-purity synthesis route for Erlotinib impurity, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel one-pot method for triamcinolone acetonide intermediate enhances yield and reduces waste. Ideal for reliable pharmaceutical intermediates supplier partnerships.
Patent CN102978249A details a single-enzyme biocatalytic route for statin intermediates. Achieve >99% ee with simplified workup and reduced manufacturing costs.
Patent CN102925501A details a high-efficiency enzymatic route for statin intermediates, offering superior purity and scalable manufacturing capabilities for global supply chains.
Patent CN101062897B details a novel Al-Ni alloy reduction for 2,3-dihydro-1H-inden-1-amine. This report analyzes cost reduction in API manufacturing and supply chain reliability.
Patent CN105732798B details a liquid-phase fragment condensation method for Liraglutide, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel Pd-catalyzed method for anti-isopentenyl azlactones. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Discover a novel hypochlorite-based purification method for 16α-hydroxyprednisolone achieving >99.5% purity. Ideal for reliable pharmaceutical intermediate sourcing.
Patent CN112125943A details a novel hypochlorite oxidation method to remove Impurity H, ensuring >99.5% purity for corticosteroid API manufacturing.
This patent details a liquid phase synthesis for Liraglutide improving purity and supply chain reliability for global pharmaceutical manufacturers seeking cost effective solutions.
Novel synthetic route for cold labeling Thiamphenicol ensures high purity and yield. Offers significant cost reduction and supply chain reliability for veterinary drug detection standards.
Patent CN101928219B details copper-catalyzed EOPB synthesis ensuring high purity and supply chain stability for ACE inhibitor production globally.
Patent CN110467580A enables high-purity Lesinurad resolution using quinoline alkaloids, ensuring cost reduction and supply reliability for pharmaceutical intermediates.
Patent CN104328148A details high-purity enzymatic synthesis. Offers cost reduction and supply chain reliability for global API manufacturers.
Novel copper-catalyzed preparation method for Vortioxetine intermediates reduces cost and improves yield for pharmaceutical manufacturing supply chains globally.
Advanced Gastrodin manufacturing via phase-transfer catalysis ensures high purity and cost efficiency. A robust solution for pharmaceutical intermediate supply chains.